Amniotic membrane transplantation in ocular surface disorders: A review

Abstract

Amniotic membrane (AM) was first used as a biomaterial in ophthalmic surgery in 1938. It was applied as a conjunctival replacement following symblepharon release. The durability, pliability and versatility of AM make it a useful adjunctive treatment in various ophthalmic procedures. This review aims to highlight the new developments, mechanisms of action, and established indications of amniotic membrane transplantation (AMT) that have been published in the last few years.

Keywords

• Amniotic membrane transplantation
• ocular surface disorder
• chemical injury